ruthenium has been researched along with Marfan Syndrome, Type I in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirata, Y; Imai, Y; Kato, M; Morota, T; Nagai, R; Nawata, K; Nishimura, H; Ogawa, N; Takamoto, S; Takeda, N; Taketani, T | 1 |
1 other study(ies) available for ruthenium and Marfan Syndrome, Type I
Article | Year |
---|---|
Circulating transforming growth factor β-1 level in Japanese patients with Marfan syndrome.
Topics: Adult; Biomarkers; Comparative Effectiveness Research; Connective Tissue; Female; Fibrillin-1; Fibrillins; Genetic Testing; Humans; Japan; Luminescent Measurements; Male; Marfan Syndrome; Microfilament Proteins; Platelet Activation; Reproducibility of Results; Ruthenium; Signal Transduction; Transforming Growth Factor beta1 | 2013 |